Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a non-coding antisense RNA transcript transcribed opposite to the SENP6 gene locus. In general, antisense transcription can play roles in modulating the chromatin environment, influencing the kinetics of sense transcript production, processing, and stability, primarily through epigenetic effects such as changes in histone acetylation and nucleosome occupancy[1][2][3]. However, “novel transcript, antisense to SENP6” (ENSG00000297132) is provisionally annotated and its function, biological impact, and relevance for drug targeting are largely uncharacterized. It is not a classic target type but may influence the regulation of the SENP6 gene, which codes for a SUMO-specific protease implicated in chromatin modification and cell cycle regulation. There are currently no known drugs or biomarkers associated with this antisense transcript, and its role in disease remains speculative without direct evidence[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to SENP6 (ENSG00000297132).